{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:27:46Z","timestamp":1788917266187,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011496","name":"Changsha Science and Technology Bureau","doi-asserted-by":"publisher","award":["k1906019"],"award-info":[{"award-number":["k1906019"]}],"id":[{"id":"10.13039\/501100011496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011496","name":"Changsha Science and Technology Bureau","doi-asserted-by":"publisher","award":["kq1901118"],"award-info":[{"award-number":["kq1901118"]}],"id":[{"id":"10.13039\/501100011496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2015JC3012"],"award-info":[{"award-number":["2015JC3012"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2020SK2080"],"award-info":[{"award-number":["2020SK2080"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770880"],"award-info":[{"award-number":["81770880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800788"],"award-info":[{"award-number":["81800788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970762"],"award-info":[{"award-number":["81970762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8217033609"],"award-info":[{"award-number":["8217033609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.gendis.2022.03.016","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T02:14:14Z","timestamp":1649643254000},"page":"1846-1856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management"],"prefix":"10.1016","volume":"10","author":[{"given":"Junaid","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-2607","authenticated-orcid":false,"given":"Hong-Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-9205","authenticated-orcid":false,"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-1554","authenticated-orcid":false,"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4204","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9745-7036","authenticated-orcid":false,"given":"Shi-Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-4141","authenticated-orcid":false,"given":"Hou-De","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2022.03.016_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","article-title":"The insulin resistance syndrome: definition and dietary approaches to treatment","volume":"25","author":"Reaven","year":"2005","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib2","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in\u00a0vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.gendis.2022.03.016_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gde.2018.02.002","article-title":"Genetic syndromes of severe insulin resistance","volume":"50","author":"Melvin","year":"2018","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib5","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/EJE-13-0327","article-title":"Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know","volume":"169","author":"Parker","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/pan.13273","article-title":"Donohue syndrome: a review of literature, case series, and anesthetic considerations","volume":"28","author":"Kirkwood","year":"2018","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pcd.2020.07.012","article-title":"Rabson-Mendenhall Syndrome in a brother-sister pair in Kuwait: diagnosis and 5 year follow up","volume":"15","author":"Al-Kandari","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"10.1016\/j.gendis.2022.03.016_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"issue":"6005","key":"10.1016\/j.gendis.2022.03.016_bib9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich","year":"1985","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2022.03.016_bib10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/diab.47.8.1362","article-title":"Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome","volume":"47","author":"Whitehead","year":"1998","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib11","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db17-0301","article-title":"Structural basis and genotype-phenotype correlations of INSR mutations causing severe insulin resistance","volume":"66","author":"Hosoe","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1073\/pnas.87.2.658","article-title":"A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction","volume":"87","author":"Kadowaki","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1043-2760(02)00662-8","article-title":"Role of Akt\/protein kinase B in metabolism","volume":"13","author":"Whiteman","year":"2002","journal-title":"Trends Endocrinol Metabol"},{"issue":"19","key":"10.1016\/j.gendis.2022.03.016_bib14","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7147","key":"10.1016\/j.gendis.2022.03.016_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator","volume":"447","author":"Li","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB beta","volume":"112","author":"Garofalo","year":"2003","journal-title":"J Clin Invest"},{"issue":"7785","key":"10.1016\/j.gendis.2022.03.016_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"issue":"6169","key":"10.1016\/j.gendis.2022.03.016_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/333183a0","article-title":"Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein","volume":"333","author":"James","year":"1988","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2337\/db07-1469","article-title":"Rab GTPase-activating protein AS160 is a major downstream effector of protein kinase B\/Akt signaling in pancreatic beta-cells","volume":"57","author":"Bouzakri","year":"2008","journal-title":"Diabetes"},{"issue":"7513","key":"10.1016\/j.gendis.2022.03.016_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature13425","article-title":"A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes","volume":"512","author":"Moltke","year":"2014","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.gendis.2022.03.016_bib21","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1093\/hmg\/ddx256","article-title":"SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase C\u025b) impairing TORC2-dependent AKT activation","volume":"26","author":"Alcantara","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.2004.00372.x","article-title":"Congenital generalized lipodystrophy: profile of the disease and gender differences in two siblings","volume":"67","author":"Raygada","year":"2005","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","article-title":"Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways","volume":"14","author":"Agarwal","year":"2003","journal-title":"Trends Endocrinol Metabol"},{"issue":"15","key":"10.1016\/j.gendis.2022.03.016_bib25","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume":"20","author":"Cui","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/hmg\/ddt444","article-title":"BSCL2\/seipin regulates adipogenesis through actin cytoskeleton remodelling","volume":"23","author":"Yang","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2013.07.009","article-title":"SnapShot: caveolae, caveolins, and cavins","volume":"154","author":"Ariotti","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cell.2007.11.042","article-title":"PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function","volume":"132","author":"Hill","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.gendis.2022.03.016_bib29","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","volume":"152A","author":"Shastry","year":"2010","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2008.07.008","article-title":"Deletion of Cavin\/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance","volume":"8","author":"Liu","year":"2008","journal-title":"Cell Metabol"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gendis.2022.03.016_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipids Health Dis"},{"issue":"8","key":"10.1016\/j.gendis.2022.03.016_bib33","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ajmg.a.37115","article-title":"Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome","volume":"167A","author":"Garg","year":"2015","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.gendis.2022.03.016_bib34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","article-title":"K\u00f6bberling type of familial partial lipodystrophy: an underrecognized syndrome","volume":"26","author":"Herbst","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome","volume":"54","author":"Guill\u00edn-Amarelle","year":"2016","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib36","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2007.03.028","article-title":"\"Laminopathies\": a wide spectrum of human diseases","volume":"313","author":"Worman","year":"2007","journal-title":"Exp Cell Res"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/ddi480","article-title":"Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy","volume":"15","author":"Boguslavsky","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.gendis.2022.03.016_bib40","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"issue":"6764","key":"10.1016\/j.gendis.2022.03.016_bib41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.gendis.2022.03.016_bib42","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0022-2275(20)41129-0","article-title":"Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes","volume":"36","author":"Blanchette-Mackie","year":"1995","journal-title":"J Lipid Res"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2022.03.016_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-008-9998-8","article-title":"Perilipin A and the control of triacylglycerol metabolism","volume":"326","author":"Brasaemle","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"10.1016\/j.gendis.2022.03.016_bib44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"issue":"47","key":"10.1016\/j.gendis.2022.03.016_bib45","doi-asserted-by":"crossref","first-page":"34213","DOI":"10.1074\/jbc.M707404200","article-title":"Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage","volume":"282","author":"Puri","year":"2007","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.gendis.2022.03.016_bib46","first-page":"2808","article-title":"FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets","volume":"118","author":"Nishino","year":"2008","journal-title":"J Clin Invest"},{"issue":"4872","key":"10.1016\/j.gendis.2022.03.016_bib47","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.3420405","article-title":"Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3","volume":"241","author":"Holm","year":"1988","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib48","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1194\/jlr.R200009-JLR200","article-title":"Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis","volume":"43","author":"Kraemer","year":"2002","journal-title":"J Lipid Res"},{"issue":"24","key":"10.1016\/j.gendis.2022.03.016_bib49","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib50","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajmg.a.37880","article-title":"Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy","volume":"173","author":"Zolotov","year":"2017","journal-title":"Am J Med Genet"},{"issue":"12","key":"10.1016\/j.gendis.2022.03.016_bib51","doi-asserted-by":"crossref","first-page":"e1007110","DOI":"10.1371\/journal.pgen.1007110","article-title":"Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice","volume":"13","author":"Xia","year":"2017","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.0022-202X.2005.23846.x","article-title":"Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy","volume":"125","author":"Moulson","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"16","key":"10.1016\/j.gendis.2022.03.016_bib53","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41588-017-0020-9","article-title":"Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity","volume":"50","author":"Siljee","year":"2018","journal-title":"Nat Genet"},{"issue":"6500","key":"10.1016\/j.gendis.2022.03.016_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/371799a0","article-title":"Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor","volume":"371","author":"Lu","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib57","first-page":"1293","article-title":"The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure","volume":"82","author":"Kennedy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6858","key":"10.1016\/j.gendis.2022.03.016_bib58","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/35101657","article-title":"Intracellular signalling. Key enzyme in leptin-induced anorexia","volume":"413","author":"Niswender","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2022.03.016_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nn885","article-title":"A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding","volume":"5","author":"Zhao","year":"2002","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.gendis.2022.03.016_bib60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/geno.1994.1638","article-title":"The gene that encodes the phosphatidylinositol-3 kinase regulatory subunit (p85 alpha) maps to chromosome 13 in the mouse","volume":"24","author":"Hoyle","year":"1994","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13256-020-2352-9","article-title":"Acromegaly with congenital generalized lipodystrophy - two rare insulin resistance conditions in one patient: a case report","volume":"14","author":"Guerreiro","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.gendis.2022.03.016_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007734","article-title":"Berardinelli-Seip syndrome: highlight of treatment challenge","volume":"2013","author":"Ferraria","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4274\/jcrpe.galenos.2018.2018.0227","article-title":"A patient with Berardinelli-Seip syndrome, novel AGPAT2 splicesite mutation and concomitant development of non-diabetic polyneuropathy","volume":"11","author":"Oswiecimska","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"10.1016\/j.gendis.2022.03.016_bib66","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-07-0393","article-title":"Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus","volume":"157","author":"Jin","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.gendis.2022.03.016_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2016.08.008","article-title":"Progressive myoclonus epilepsy in congenital generalized lipodystrophy type 2: report of 3 cases and literature review","volume":"42","author":"Opri","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.gendis.2022.03.016_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gene.2017.09.023","article-title":"Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy","volume":"637","author":"Chen","year":"2017","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.gendis.2022.03.016_bib69","doi-asserted-by":"crossref","first-page":"e0131797","DOI":"10.1371\/journal.pone.0131797","article-title":"A frame-shift mutation in CAV1 is associated with a severe neonatal progeroid and lipodystrophy syndrome","volume":"10","author":"Schrauwen","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.gendis.2022.03.016_bib70","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/tra.12452","article-title":"Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy","volume":"17","author":"Han","year":"2016","journal-title":"Traffic"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib71","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmg.2015.02.002","article-title":"Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family","volume":"58","author":"Jelani","year":"2015","journal-title":"Eur J Med Genet"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nmd.2013.02.005","article-title":"Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood","volume":"23","author":"Murakami","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.gendis.2022.03.016_bib73","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2016-1086","article-title":"Maladaptative autophagy impairs adipose function in congenital generalized lipodystrophy due to Cavin-1 deficiency","volume":"101","author":"Salle-Teyssi\u00e8res","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gendis.2022.03.016_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2350-14-89","article-title":"Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy","volume":"14","author":"Ardissone","year":"2013","journal-title":"BMC Med Genet"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib75","doi-asserted-by":"crossref","first-page":"e1000874","DOI":"10.1371\/journal.pgen.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations","volume":"6","author":"Rajab","year":"2010","journal-title":"PLoS Genet"},{"issue":"6\u20137","key":"10.1016\/j.gendis.2022.03.016_bib76","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmg.2016.05.001","article-title":"Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4","volume":"59","author":"Akinci","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"24","key":"10.1016\/j.gendis.2022.03.016_bib77","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1073\/pnas.1408523111","article-title":"Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease","volume":"111","author":"Payne","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ejhg.2017.23","article-title":"Mutations in the PCYT1A gene are responsible for isolated forms of retinal dystrophy","volume":"25","author":"Testa","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gendis.2022.03.016_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.12837","article-title":"Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3","volume":"84","author":"Miehle","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.gendis.2022.03.016_bib81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejmg.2014.06.006","article-title":"Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome","volume":"57","author":"Dyment","year":"2014","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/db14-0104","article-title":"Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy","volume":"64","author":"Kozusko","year":"2015","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.gendis.2022.03.016_bib83","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic challenge in PLIN1-associated familial partial lipodystrophy","volume":"104","author":"J\u00e9ru","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12882-018-0913-6","article-title":"The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature","volume":"19","author":"Chen","year":"2018","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2022.03.016_bib85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib86","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.gendis.2022.03.016_bib87","first-page":"omz062","article-title":"Oil Red-O Positive lipid blobs on peripheral blood film examination in a muscular infant with the diagnosis of Berardinelli-Seip syndrome","volume":"2019","author":"Chaudhary","year":"2019","journal-title":"Oxf Med Case Reports"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2022.03.016_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.12.032","article-title":"Clinical and molecular aspects of Berardinelli-Seip congenital lipodystrophy (BSCL)","volume":"402","author":"Gomes","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.gendis.2022.03.016_bib89","series-title":"GeneReviews(\u00ae)","article-title":"Berardinelli-seip congenital lipodystrophy","author":"Van Maldergem","year":"1993"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ando.2012.11.008","article-title":"AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome","volume":"74","author":"Rostami","year":"2013","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"10.1016\/j.gendis.2022.03.016_bib91","doi-asserted-by":"crossref","first-page":"103542","DOI":"10.1016\/j.ejmg.2018.09.009","article-title":"Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants","volume":"62","author":"Liu","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib92","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4274\/jcrpe.v2i4.176","article-title":"Monogenic diabetes secondary to congenital lipodystrophy in a 14-year-old Yemeni girl","volume":"2","author":"Roth","year":"2010","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/03007995.2018.1533459","article-title":"Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases","volume":"35","author":"Vatier","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.gendis.2022.03.016_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1297\/cpe.28.139","article-title":"The long-term management of congenital generalized lipodystrophy (Berardinelli-Seip syndrome): the clinical manifestations of Japanese siblings for approximately 20 years","volume":"28","author":"Maeda","year":"2019","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.gendis.2022.03.016_bib95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2350-15-71","article-title":"Exome sequencing circumvents missing clinical data and identifies a BSCL2 mutation in congenital lipodystrophy","volume":"15","author":"Schuster","year":"2014","journal-title":"BMC Med Genet"},{"issue":"6","key":"10.1016\/j.gendis.2022.03.016_bib96","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jelectrocard.2017.08.001","article-title":"PDF-ECG in clinical practice: a model for long-term preservation of digital 12-lead ECG data","volume":"50","author":"Sassi","year":"2017","journal-title":"J Electrocardiol"},{"issue":"1","key":"10.1016\/j.gendis.2022.03.016_bib97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmg.2008.10.006","article-title":"Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation","volume":"52","author":"Friguls","year":"2009","journal-title":"Eur J Med Genet"},{"issue":"3","key":"10.1016\/j.gendis.2022.03.016_bib98","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2265.2010.03810.x","article-title":"What is the best management strategy for patients with severe insulin resistance?","volume":"73","author":"Semple","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib99","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1111\/j.1464-5491.2012.03742.x","article-title":"A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation","volume":"29","author":"Madhra","year":"2012","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-5491.2010.03052.x","article-title":"Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy","volume":"27","author":"Victoria","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.gendis.2022.03.016_bib101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2015.10.057","article-title":"Effects of Thiazolidinediones on metabolism and cancer: relative influence of PPAR\u03b3 and IGF-1 signaling","volume":"768","author":"Mughal","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.gendis.2022.03.016_bib102","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/dme.13061","article-title":"Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -\u03b3 (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A\/C (LMNA) mutations","volume":"33","author":"Demir","year":"2016","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.gendis.2022.03.016_bib103","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00125-010-1879-5","article-title":"Multidrug therapy in a patient with Rabson-Mendenhall syndrome","volume":"53","author":"Moreira","year":"2010","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2022.03.016_bib104","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1530\/EJE-07-0271","article-title":"IGF-I treatment of insulin resistance","volume":"157","author":"McDonald","year":"2007","journal-title":"Eur J Endocrinol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304222000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304222000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:30:57Z","timestamp":1762450257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304222000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2352304222000915"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2022.03.016","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2022.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}